WARS2 and neoplasm: Functional comparisons between WARS2-positive and -negative cancer cells showed that the former exhibited higher metabolic activity and intercellular communication potential, particularly within adhesion-related pathways such as CD99, CDH, and FN1, potentially promoting cooperative tumor growth and immune evasion.